Nano-Farmasötikler
Özet
Nanofarmasötikler, nanometre boyutundaki partiküllerin ilaç taşıma, kontrollü salım ve biyoyararlanımı artırma gibi avantajlar sunarak modern tıpta devrim yaratan bir alandır. Bu sistemler, organik (lipozomlar, polimerik nanopartiküller) ve inorganik (altın, gümüş nanopartiküller) olarak sınıflandırılır. Lipozomlar, ilaçları hedef dokulara taşımada etkiliyken, polimerik nanopartiküller uzun süreli salım sağlar. İnorganik nanopartiküller ise teranostik (tedavi ve teşhis) uygulamalarda kullanılır. Nanofarmasötiklerin üretiminde fiziksel (homojenizasyon, ultrasonikasyon) ve kimyasal (emülsifikasyon, sol-jel) yöntemler öne çıkar. Kanser tedavisinde hedefli ilaç taşıma, enfeksiyonlarda antimikrobiyal etki ve nörolojik hastalıklarda kan-beyin bariyerini aşma gibi uygulamaları vardır. Gelecekte, yapay zeka entegrasyonu, biyomimetik materyaller ve nano-robotik sistemler gibi yenilikçi yaklaşımlar nanofarmasötiklerin potansiyelini daha da artıracaktır.
Nanopharmaceuticals are a field that has revolutionized modern medicine by offering advantages such as drug delivery, controlled release and increased bioavailability of nanometer sized particles. These systems are classified as organic (liposomes, polymeric nanoparticles) and inorganic (gold, silver nanoparticles). Liposomes are effective in delivering drugs to target tissues, while polymeric nanoparticles provide long term release. Inorganic nanoparticles are used in theranostic (treatment and diagnosis) applications. Physical (homogenization, ultrasonication) and chemical (emulsification, sol-gel) methods are prominent in the production of nanopharmaceuticals. They have applications such as targeted drug delivery in cancer treatment, antimicrobial effect in infections and overcoming the blood-brain barrier in neurological diseases. In the future, innovative approaches such as AI integration, biomimetic materials, and nano-robotic systems will further increase the potential of nanopharmaceuticals.
Referanslar
Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: Recent developments and future prospects. Journal of Nanobiotechnology. 2018; 16(1), 71. https://doi.org/10.1186/s12951-018-0392-8
Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nature Reviews Drug Discovery. 2021; 20(2), 101-124. https://doi.org/10.1038/s41573-020-0090-8
Zhang L, Gu FX, Chan JM, et al. Nanoparticles in medicine: Therapeutic applications and developments. Clinical Pharmacology & Therapeutics. 2008; 83(5), 761-769. https://doi.org/10.1038/sj.clpt.6100400
Joudeh N, Linke D. Nanoparticle classification, physicochemical properties, characterization, and applications: a comprehensive review for biologists. Journal of Nanobiotechnology. 2022; 20, 262. https://doi.org/10.1186/s12951-022-01477-8
Bulbake U, Doppalapudi S, Kommineni N, et al. Liposomal formulations in clinical use: An updated review. Pharmaceutics. 2017; 9(2), 12. https://doi.org/10.3390/pharmaceutics9020012,
Alexis F, Pridgen E, Molnar LK, et al. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Molecular Pharmaceutics. 2008; 5(4), 505-515. https://doi.org/10.1021/mp800051m
Suk JS, Xu Q, Kim N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Advanced Drug Delivery Reviews. 2016; 99, 28-51. http://dx.doi.org/10.1016/j.addr.2015.09.012
Ezike TC, Okpala US, Onoja UL, et al. Advances in drug delivery systems, challenges and future directions. Heliyon. 2023; 9(6):e17488. doi:10.1016/j.heliyon.2023.e17488.
Yusuf A, Almotairy ARZ, Henidi H, et al. Nanoparticles as Drug Delivery Systems: A Review of the Implication of Nanoparticles' Physicochemical Properties on Responses in Biological Systems. Polymers. 2023; 15(7), 1596. https://doi.org/10.3390/polym15071596
Shi J, Votruba AR, Farokhzad OC, et al. Nanotechnology in drug delivery and tissue engineering: From discovery to applications. Nano Letters. 2010; 10(9), 3223-3230. https://doi.org/10.1021/nl102184c
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, et al. Liposome: Classification, preparation, and applications. Nanoscale Research Letters. 2013; 8(1), 102. https://doi.org/10.1186/1556-276X-8-102
Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery. 2005; 4(2), 145-160. https://doi.org/10.1038/nrd1632
Immordino ML, Dosio F, Cattel L. Stealth liposomes: Review of the basic science, rationale, and clinical applications, existing and potential. International Journal of Nanomedicine. 2006; 1(3), 297. https://doi.org/10.2147/DIJN.1.S633
Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics. 2000; 50(1), 161-177. https://doi.org/10.1016/S0939-6411(00)00087-4
Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. International Journal of Pharmaceutics. 2009; 366(1-2), 170-184. https://doi.org/10.1016/j.ijpharm.2008.10.003
Das S, Ng WK, Tan RB. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? European Journal of Pharmaceutical Sciences. 2012; 47(1), 139-151. https://doi.org/10.1016/j.ejps.2012.05.010
Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces. 2010; 75(1), 1-18. https://doi.org/10.1016/j.colsurfb.2009.09.001
Mohammed MA, Syeda JTM, Wasan KM, et al. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017; 9(4), 53. https://doi.org/10.3390/pharmaceutics9040053
Langer K, Anhorn MG, Steinhauser I, et al. Human serum albumin (HSA) nanoparticles: Reproducibility of preparation process and kinetics of enzymatic degradation. International Journal of Pharmaceutics. 2003; 347(1-2), 109-117. https://doi.org/10.1016/j.ijpharm.2007.06.028
Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: An overview of biomedical applications. Journal of Controlled Release. 2012; 161(2), 505-522. http://dx.doi.org/10.1016/j.jconrel.2012.01.043
Woodruff MA, Hutmacher DW. The return of a forgotten polymer—polycaprolactone in the 21st century. Progress in Polymer Science. 2010; 35(10), 1217-1256. https://doi.org/10.1016/j.progpolymsci.2010.04.002
Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature Materials. 2013; 12(11), 991-1003. https://doi.org/10.1038/nmat3776
Caminade AM, Turrin CO. Dendrimers for drug delivery. Journal of Materials Chemistry B. 2014; 2, 4055-4066. https://doi.org/10.1039/C4TB00171K
Mintzer MA, Grinstaff MW. Biomedical applications of dendrimers: A tutorial. Chemical Society Reviews. 2011; 40(1), 173-190. DOI: 10.1039/B901839P
Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Advanced Drug Delivery Reviews. 2012; 64, 102-115. https://doi.org/10.1016/j.addr.2012.09.030
Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Progress in Polymer Science. 2014; 39(2), 268-307. https://doi.org/10.1016/j.progpolymsci.2013.07.005
Bianco A, Kostarelos K, Prato M. Applications of carbon nanotubes in drug delivery. Current Opinion in Chemical Biology. 2005; 9(6), 674-679. https://doi.org/10.1016/j.cbpa.2005.10.005
Kostarelos K, Lacerda L, Pastorin G, et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nature Nanotechnology. 2007; 2(2), 108-113. https://doi.org/10.1038/nnano.2006.209
Klumpp C, Kostarelos K, Prato M, et al. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. Biochimica et Biophysica Acta. 2006; 1758(3), 404-412. https://doi.org/10.1016/j.bbamem.2005.10.008
Firme CP, Bandaru PR. Toxicity issues in the application of carbon nanotubes to biological systems. Nanomedicine: Nanotechnology, Biology and Medicine. 2010; 6(2), 245-256. https://doi.org/10.1016/j.nano.2009.07.003
Riley RS, Day ES. Gold nanoparticle-mediated photothermal therapy: Applications and opportunities for multimodal cancer treatment. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2017; 9(4), e1449. https://doi.org/10.1002/wnan.1449
Dreaden EC, Alkilany AM, Huang X, et al. The golden age: Gold nanoparticles for biomedicine. Chemical Society Reviews. 2012; 41(7), 2740-2779. https://doi.org/10.1039/C1CS15237H
Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnology Advances. 2009; 27(1), 76-83 https://doi.org/10.1016/j.biotechadv.2008.09.002
AshaRani PV, Low Kah Mun G, Hande MP, et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2009; 3(2), 279-290. https://doi.org/10.1021/nn800596w
Slowing II, Vivero-Escoto JL, Wu CW, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Advanced Drug Delivery Reviews. 2008; 60(11), 1278-1288. https://doi.org/10.1016/j.addr.2008.03.012
Vivero-Escoto JL, Slowing II, Trewyn BG, et al. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Nano-Micro Small. 2010; 6(18), 1952-1967. https://doi.org/10.1002/smll.200901789
Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chemical Reviews. 2008; 108(6), 2064-2110. https://doi.org/10.1021/cr068445e
Mahmoudi M, Sant S, Wang B, et al. Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Advanced Drug Delivery Reviews. 2011; 63(1-2), 24-46. https://doi.org/10.1016/j.addr.2010.05.006
Singh R, Lillard JW. Nanoparticle-based targeted drug delivery, Experimental and Molecular Pathology. 2009; 86(3), 215-223. https://doi.org/10.1016/j.yexmp.2008.12.004.
Jeevanandam J, Barhoum A, Chan YS, et al. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein Journal of Nanotechnology. 2018; 9, 1050-1074. https://doi.org/10.3762/bjnano.9.98
Kumari S, Raturi S, Kulshreshta S, et al. A comprehensive review on various techniques used for synthesizing nanoparticles. Journal of Materials Research and Technology. 2023; 27, 1739-1763. https://doi.org/10.1016/j.jmrt.2023.09.291
Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. International Journal of Pharmaceutics. 2010; 399(1-2), 129-139. https://doi.org/10.1016/j.ijpharm.2010.07.044
Date AA, Desai N, Dixit R, et al. Self-nanoemulsifying drug delivery systems: formulation and in vitro evaluation. Nanomedicine. 2010; 5(10), 1595–1616. https://doi.org/10.2217/nnm.10.126
Abismail B, Canselier JP, Wilhelm AM, et al. Emulsification by ultrasound: drop size distribution and stability. Ultrasonics Sonochemistry. 1999; 6(1-2), 75-83. https://doi.org/10.1016/S1350-4177(98)00027-3
Keck CM, Müller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. European Journal of Pharmaceutics and Biopharmaceutics. 2006; 62(1), 3-16. https://doi.org/10.1016/j.ejpb.2005.05.009Get rights and content
Chen H, Khemtong C, Yang X, et al. Nanonization strategies for drug delivery systems. Drug Discovery Today. 2011; 16(7-8), 354-360. https://doi.org/10.1016/j.drudis.2010.02.009
Kakran M, Sahoo NG, Tan IL, et al. Preparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methods. Journal of Nanoparticle Research. 2012; 14(3), 757. https://doi.org/10.1007/s11051-012-0757-0
Sahana DK, Mittal G, Bhardwaj V, et al. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. Journal of Pharmaceutical Sciences. 2008; 97(4), 1530-1542. https://doi.org/10.1002/jps.21158
Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Progress in Polymer Science. 2011; 36(7), 887-913. https://doi.org/10.1016/j.progpolymsci.2011.01.001
Bilati U, Allémann E, Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano-and microparticles. European Journal of Pharmaceutics and Biopharmaceutics. 2005; 59(3), 375-388. https://doi.org/10.1016/j.ejpb.2004.10.006
Livage J, Henry M, Sanchez C. Sol-gel chemistry of transition metal oxides. Progress in Solid State Chemistry. 1988; 18(4), 259-341. https://doi.org/10.1016/0079-6786(88)90005-2
Borlaf M, Moreno R. Colloidal sol-gel: A powerful low-temperature aqueous synthesis route of nanosized powders and suspensions. Open Ceramics. 2021; 8, 100200. https://doi.org/10.1016/j.oceram.2021.100200
Lawrence MJ, Rees, GD. Microemulsion-based media as novel drug delivery systems. Advanced Drug Delivery Reviews. 2000; 45(1), 89-121. https://doi.org/10.1016/S0169-409X(00)00103-4
Capek I. Preparation of metal nanoparticles in water-in-oil (w/o) microemulsions. Advances in Colloid and Interface Science. 2004; 110(1-2), 49-74. https://doi.org/10.1016/j.cis.2004.02.003
Ovais M, Khalil AT, Raza A, et al. Green synthesis of silver nanoparticles via plant extracts: beginning a new era in cancer theranostics. Nanomedicine. 2016; 13(23), 3157-3177. https://doi.org/10.2217/nnm-2016-0279
Iravani S. Bacteria in nanoparticle synthesis: current status and future prospects. International Scholarly Research Notices. 2014; 2014, 359316. https://doi.org/10.1155/2014/359316
Mittal AK, Chisti Y, Banerjee UC. Synthesis of metallic nanoparticles using plant extracts. Biotechnology Advances. 2013; 31(2), 346-356. https://doi.org/10.1016/j.biotechadv.2013.01.003
Duan H, Wang D, Li Y. Green chemistry for nanoparticle synthesis. Chemical Society Reviews. 2015; 44(16), 5778-5792. https://doi.org/10.1039/c4cs00363b
Ajith S, Almomani F, Elhissi A, et al. Nanoparticle-based materials in anticancer drug delivery: Current and future prospects. Heliyon. 2023; 9(11), e21227. https://doi.org/10.1016/j.heliyon.2023.e21227
Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of Controlled Release. 2000 65(1-2), 271-284. https://doi.org/10.1016/S0168-3659(99)00248-5
Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nature Reviews Drug Discovery. 2014; 13(11), 813-827. https://doi.org/10.1038/nrd4333
Barenholz Y. Doxil®—the first FDA-approved nano-drug: lessons learned. Journal of Controlled Release. 2012; 160(2), 117-134. https://doi.org/10.1016/j.jconrel.2012.03.020
Gradishar WJ, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil–based paclitaxel in women with breast cancer. Journal of Clinical Oncology. 2005; 23(31), 7794-7803. https://doi.org/10.1200/JCO.2005.04.937
Malik N, Wiwattanapatapee R, Klopsch R, et al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. Journal of Controlled Release. 2000; 65(1-2), 133-148. https://doi.org/10.1016/S0168-3659(99)00246-1
Grebowski J, Litwinienko G. Metallofullerenols in biomedical applications. European Journal of Medicinal Chemistry. 2022; Volume 238, 114481. https://doi.org/10.1016/j.ejmech.2022.114481
Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, et al. Mode of antiviral action of silver nanoparticles against HIV-1. Journal of Nanobiotechnology. 2010; 8(1), 1-10. https://doi.org/10.1186/1477-3155-8-1
Das Neves J, Bahia MF, Amiji MM, et al. Mucoadhesive nanomedicines: characterization and modulation of mucoadhesive interactions for drug delivery. Expert Opinion on Drug Delivery. 2011; 8(8), 1085-1104. https://doi.org/10.1517/17425247.2011.586334
Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines—a new era in vaccinology. Nature Reviews Drug Discovery. 2018; 17(4), 261-279. https://doi.org/10.1038/nrd.2017.243
Thomsen MS, Johnsen KB, Kucharz K, et al. Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles. Pharmaceutics. 2022; 14(10), 2237. https://doi.org/10.3390/pharmaceutics14102237
Hartl N, Adams F, Merkel OM. From adsorption to covalent bonding: Apolipoprotein E functionalization of polymeric nanoparticles for drug delivery across the blood-brain barrier. Advanced therapeutics. 2020; 4(1), 2000092. https://doi.org/10.1002/adtp.202000092
Tiwari SK, Agarwal S, Seth B, et al. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway. ACS Nano. 2014; 8(1), 76-103. DOI: 10.1021/nn405077y
Julien DC, Behnke S, Wang G, et al. Utilization of monoclonal antibody-targeted nanomaterials in the treatment of cancer. mAbs. 2011; 3(5), 467–478. https://doi.org/10.4161/mabs.3.5.16089
Md S, Khan RA, Mustafa G, et al. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: Pharmacodynamic, Pharmacokinetic and Scintigraphy study in mice model. European Journal of Pharmaceutical Sciences. 2013; 48 (3), 393-405. https://doi.org/10.1016/j.ejps.2012.12.007
Thaxton CS, Daniel WL, Giljohann DA, et al. Templated spherical high density lipoprotein nanoparticles. Journal of the American Chemical Society. 2009; 131(4), 1384-1385. https://doi.org/10.1021/ja808856z
Pedro F, Gonçalves MBS, Lohani A, et al. Advancing atherosclerosis treatment: Drug encapsulation nanosystems and synthetic HDL nanoparticles. Drug Discovery Today. 2025; 30, (6), 104370. https://doi.org/10.1016/j.drudis.2025.104370
Formiga FR, Pelacho B, Garbayo E, et al. Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia–reperfusion model. Journal of Controlled Release. 2010; 147(1), 30-37. https://doi.org/10.1016/j.jconrel.2010.07.097
Marsh JN, Senpan A, Hu G, et al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomedicine. 2007; 2(4), 533-543. https://doi.org/10.2217/17435889.2.4.533
Peeters L, Sanders NN, Braeckmans K, et al. Vitreous: a barrier to nonviral ocular gene therapy. Investigative Ophthalmology & Visual Science. 2005; 46(10), 3553-3561. https://doi.org/10.1167/iovs.05-0165
De Campos AM, Diebold Y, Carvalho EL, et al. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharmaceutical Research. 2004; 21(5), 803-810. https://doi.org/10.1023/B:PHAM.0000026432.75781.cb
Pan Y, Li YJ, Zhao HY, et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. International Journal of Pharmaceutics. 2002; 249(1-2), 139-147. https://doi.org/10.1016/S0378-5173(02)00486-6
Kataoka K, Miyazaki H, Bunya M, et al. Totally synthetic polymer gels responding to external glucose concentration: their preparation and application to on−off regulation of insulin release. Journal of the American Chemical Society. 1998; 120(48), 12694-12695. DOI: 10.1021/ja982975d
Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, et al. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis & Rheumatism. 2003; 48(7), 2059-2066. https://doi.org/10.1002/art.11140
Palazzo B, Iafisco M, Laforgia M, et al. Biomimetic hydroxyapatite–drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Advanced Functional Materials. 2007; 17(13), 2180-2188. https://hdl.handle.net/11586/119446
Yang W, Peters JI, Williams III RO. Inhaled nanoparticles—a current review. International Journal of Pharmaceutics. 2008; 356(1-2), 239-247. https://doi.org/10.1016/j.ijpharm.2008.02.011
Verschraegen CF, Gilbert BE, Loyer E, et al. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20 (S)-camptothecin in patients with advanced pulmonary malignancies. Clinical Cancer Research. 2004; 10(7), 2319-2326. https://doi.org/10.1158/1078-0432.CCR-0929-3
Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Advanced Drug Delivery Reviews. 2002; 54, S131-S155. https://doi.org/10.1016/S0169-409X(02)00118-7
Serpone N, Dondi D, Albini A. Inorganic and organic UV filters: their role and efficacy in sunscreens and suncare products. Inorganica Chimica Acta. 2007; 360(3), 794-802. https://doi.org/10.1016/j.ica.2005.12.057
Markman M, Zanotti K, Webster K, et al. Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary peritoneal carcinoma. Gynecologic Oncology. 2006; 103(3), 1004-1007. https://doi.org/10.1016/j.ygyno.2003.08.001
GuhaSarkar S, Banerjee R. Intravesical drug delivery: challenges, current status, opportunities and novel strategies. Journal of Controlled Release. 2010; 148(2), 147-159. https://doi.org/10.1016/j.jconrel.2010.08.031
Desai N, Trieu V, Yao Z, et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clinical Cancer Research. 2006; 12(4), 1317-1324. https://doi.org/10.1158/1078-0432.CCR-05-1634
Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Advanced Drug Delivery Reviews. 2008; 60(8), 915-928. https://doi.org/10.1016/j.addr.2007.05.017
Anselmo AC, Mitragotri S. Nanoparticles in the clinic: An update. Bioengineering & Translational Medicine. 2019; 1(1), 10-29. https://doi.org/10.1002/btm2.10143
Teleanu DM, Chircov C, Grumezescu AM, et al. Antioxidant therapies for neuroprotection—a review. Journal of Clinical Medicine. 2019; 7(10), 317. https://doi.org/10.3390/jcm8101659
Etheridge ML, Campbell SA, Erdman AG, et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine: Nanotechnology, Biology and Medicine. 2013; 9(1), 1-14. https://doi.org/10.1016/j.nano.2012.05.013
Ekins S, Puhl AC, Zorn KM, et al. Exploiting machine learning for end-to-end drug discovery and development. Nature Materials. 2019; 18(5), 435-441. https://doi.org/10.1038/s41563-019-0338-z
Hu CMJ, Zhang L, Aryal S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proceedings of the National Academy of Sciences. 2011; 108(27), 10980-10985. https://doi.org/10.1073/pnas.1106634108
Douglas SM, Bachelet I, Church GM. A logic-gated nanorobot for targeted transport of molecular payloads. Science. 2012; 335(6070), 831-834. DOI: 10.1126/science.1214081
